Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for anesthesia during ordinary and complex bronchoscopy
ChiCTR2100053266Phase 4Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and propofol in Chest diseases (4 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoints: Incidence of hypoxemia and BPS analgesia score. Started Nov 2021; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Chest diseases
Beyond the preview
Go deeper on ChiCTR2100053266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053266.